Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;5(10):207.
doi: 10.21037/atm.2017.03.102.

External beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applications

Affiliations
Review

External beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applications

Omar Mahmoud et al. Ann Transl Med. 2017 May.

Abstract

The management of locally advanced cervical cancer relies on brachytherapy (BT) as an integral part of the radiotherapy delivery armamentarium. Occasionally, intracavitary BT is neither possible nor available. In these circumstances, post-external beam radiotherapy (EBRT) interstitial brachytherapy and/or hysterectomy may represent viable options that must be adequately executed in a timely manner. However, if these options are not applicable due to patient related or facility related reasons, a formal contingency plan should be in place. Innovative EBRT techniques such as intensity modulated and stereotactic radiotherapy may be considered for patients unable to undergo brachytherapy. Relying on provocative arguments and recent data, this review explores the rationale for and limitations of non-brachytherapy substitutes in that setting aiming to establish a formal process for the optimal execution of this alternative plan.

Keywords: Cervical cancer; brachytherapy alternative; intensity modulated radiation therapy (IMRT); robotic radiosurgery; stereotactic body radiotherapy (SBRT).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
BED10 difference between SIF and CF dose fractionation favoring SIF except in high α with long Tk and long Tpot. CF, conventionally fractionated schedule; SIF, short integrated fractionation schedule; TK, tumor kick off time in days for the start of accelerated repopulation; Tpot, potential tumor doubling time in days.
Figure 2
Figure 2
TCP as a function of tumor volume comparing short integrated versus conventional technique fractionation schedules. CF, conventionally fractionated schedule; SIF, short integrated fractionation schedule; TCP, tumor control probability.
Figure 3
Figure 3
Example of patient set up and SBRT plan to deliver cervical boost in case of brachytherapy non-applicability. (A) Reverse trendelenburg position; (B) the support device attached to the treatment board to permit insertion of vaginal applicator in the vagina reducing cervical tumor motion; (C,D) showing the axial and the sagittal dose distribution of SBRT boost. SBRT, stereotactic body radiotherapy.

Similar articles

Cited by

References

    1. Cancer IAfRo. Cervical cancer estimated incidence, mortality and prevalence worldwide in 2012. World Health Organization. Available online: http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30. 10.3322/caac.21332 - DOI - PubMed
    1. Henschke UK. “Afterloading” applicator for radiation therapy of carcinoma of the uterus. Radiology 1960;74:834. 10.1148/74.5.834 - DOI - PubMed
    1. Viswanathan AN, Thomadsen B. American Brachytherapy Society Cervical Cancer Recommendations C, American Brachytherapy S. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy 2012;11:33-46. 10.1016/j.brachy.2011.07.003 - DOI - PubMed
    1. Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer 1983;51:959-67. 10.1002/1097-0142(19830301)51:5<959::AID-CNCR2820510533>3.0.CO;2-K - DOI - PubMed

LinkOut - more resources